EMBC

Embecta Corp. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2025-11-25

Figures on this page computed 2026-11-08 12:24 UTC

Last close

6.52USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2025-11-25

3.8xP/E
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001872789-25-000036
Reported in
USD
- computed
- 10-K for 2025, filed 2025-11-25
The filing itself
29.7%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001872789-25-000036
Reported in
USD
- 10-K for 2025, filed 2025-11-25
- 10-K for 2025, filed 2025-11-25
- 10-K for 2025, filed 2025-11-25
- 10-Q for 2025, filed 2026-08-07
- 10-K for 2025, filed 2025-11-25
- 10-Q for 2025, filed 2026-08-07
The filing itself
8.8%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001872789-25-000036
Reported in
USD
- 10-K for 2025, filed 2025-11-25
- 10-K for 2025, filed 2025-11-25
The filing itself
16.9%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001872789-25-000036
Reported in
USD
- 10-K for 2025, filed 2025-11-25
- 10-K for 2025, filed 2025-11-25
The filing itself
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001872789-25-000036
Reported in
USD
- 10-K for 2025, filed 2025-11-25
- 10-Q for 2025, filed 2026-08-07
The filing itself
5.2%Dividend yield
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
- computed
- computed
- computed
- computed
- Computed from the filing for 2025, filed 2025-11-25

Growth is the furthest below its sector's middle: 0.28 against 0.47 on the market's range.

Five bars, one line

lens 7 of 9

0.97x

0.44x

0.73x

1.13x

0.38x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-04

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2025, filed 2025-11-25

Sales0.97x
Its own average over 6 years, 1.12B.
Profit0.44x
Its own average over 6 years, 218.3M.
Free cash flow0.73x
Its own average over 6 years, 251.4M.
Debt1.13x
Its own average over 5 years, 1.28B.
Price0.38x
Its own average over 5 years, 17. Market data, 2026-11-04

Price is furthest from its own average, at 0.38 times.

Sales is 0.97 times its own 6-year average; Profit is 0.44 times its own 6-year average; Free cash flow is 0.73 times its own 6-year average; Debt is 1.13 times its own 5-year average; Price is 0.38 times its own 5-year average.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2025-11-25

Sales against its own 6-year average0.97
Source
filed
Statement
income
Fiscal year
2025
Accession
0001872789-25-000036
Reported in
USD
The filing itself
Profit against its own 6-year average0.44
Source
filed
Statement
income
Fiscal year
2025
Accession
0001872789-25-000036
Reported in
USD
The filing itself
Free cash flow against its own 6-year average0.73
Source
filed
Statement
income
Fiscal year
2025
Accession
0001872789-25-000036
Reported in
USD
The filing itself
Debt against its own 5-year average1.13
Source
filed
Statement
income
Fiscal year
2025
Accession
0001872789-25-000036
Reported in
USD
The filing itself
Price against its own 5-year average0.38Market data, 2026-11-04
Source
market
Taken on
2026-11-04
Reported in
USD